Article
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant…
medRxiv · 2022 · Lauren E. Stopfer
Key facts
| Title | MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas |
|---|---|
| First author | Lauren E. Stopfer |
| Journal | medRxiv |
| Published | May 23, 2022 |
| DOI | 10.1101/2022.01.10.475285 |
| Devices mentioned | K073490, K822496 |
| Product codes mentioned | CFN, JIT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1